Emisphere Technologies, Inc. is a commercial-stage pharmaceutical and drug delivery company based in Roseland, New Jersey, specializing in innovative technologies to enhance the oral bioavailability of therapeutic compounds. The company focuses on utilizing its proprietary Eligen® Technology platform to transform a variety of molecules, including biologics, into orally deliverable medications. Emisphere aims to improve patient compliance and expand the therapeutic potential of existing drugs, positioning itself as a key player in the evolving pharmaceutical landscape.